drugset / Trial / NCT07645430

Assessment of Interleukin-15 and Interferon Gamma in Alopecia Areata Before and After Baricitinib.

NCT07645430

Completed 20 enrolled Benha University
NaSingle-groupOpen-labelTreatment

Summary

The primary objective of this study was to evaluate the change in serum interferon gamma and Interleukin-15 levels before and after use of oral drug baricitinib therapy. Venous blood samples (5 mL) were collected from each participant at baseline and at six months.

Timeline

Start
2023-01-01
Primary completion
2024-01-01
Completion
2026-06-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Baricitinib Small molecule 4 mg Oral

Indications